AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33978334 — intervention group
Group type: EXPERIMENTAL
Intervention: G2 - Instructor feedback with app visibility only for instructor
Number of subjects: 0
Study 33978334 — intervention group
Group type: COMPARATOR
Intervention: G3 - Control group with no app visibility
Number of subjects: 0
Study 32790699 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious music
Number of subjects: 408
Study 32790699 — intervention group
Group type: EXPERIMENTAL
Intervention: Secular music
Number of subjects: 408
Study 32790699 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 408
Study 32790699 — intervention group
Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 408
Study 36324139 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue 0.025% + conventional therapy (CTx)
Number of subjects: 60
Study 36324139 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue 0.05% + conventional therapy (CTx)
Number of subjects: 60
Study 36324139 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue 0.1% + conventional therapy (CTx)
Number of subjects: 60
Study 36324139 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CTx) alone
Number of subjects: 60
Study 33801019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid supplementation, 745 mg daily for an average of 12.4 years
Number of subjects: 9664
Study 33801019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid dietary intake
Number of subjects: 9664
Study 33801019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid blood concentration
Number of subjects: 9664
Study 33095030 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 14
Study 33095030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 32112556 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care intervention (quarterly AF check-ups by trained nurses, monitoring of anticoagulation therapy, consultations from cardiologists)
Number of subjects: 1240
Study 32112556 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1240
Study 32112556 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care intervention
Number of subjects: 1240
Study 35136417 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual reduction (treatment group)
Number of subjects: 40
Study 35136417 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 35136417 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 33964855 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg vitamin D3/d
Number of subjects: 240
Study 33964855 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg vitamin D3/d
Number of subjects: 240
Study 33964855 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 240
Study 32638614 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) plus routine physical therapy
Number of subjects: 50
Study 32638614 — intervention group
Group type: COMPARATOR
Intervention: Sham HILT plus routine physical therapy
Number of subjects: 50
Study 34716820 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish massage (SM)
Number of subjects: 90
Study 34716820 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential electrical stimulation (IES)
Number of subjects: 90
Study 34716820 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 33972995 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 8291
Study 32434359 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual 23G silicone oil removal method
Number of subjects: 130
Study 32434359 — intervention group
Group type: COMPARATOR
Intervention: Vitrectomy system
Number of subjects: 130
Study 34989171 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (800 IU/day) for 28 days
Number of subjects: 112
Study 34989171 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin D supplementation)
Number of subjects: 112
Study 34938826 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day 50% reduction in time spent on social media (Facebook, Instagram, Snapchat, YouTube)
Number of subjects: 76
Study 34938826 — intervention group
Group type: COMPARATOR
Intervention: 10% reduction in time spent on social media (Control group)
Number of subjects: 76
Study 34938826 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall participant behavior
Number of subjects: 76
Study 36067484 — intervention group
Group type: EXPERIMENTAL
Intervention: Polylactic acid membrane
Number of subjects: 60
Study 36067484 — intervention group
Group type: COMPARATOR
Intervention: Polyurethane film
Number of subjects: 60
Study 33048879 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine
Number of subjects: 0
Study 33048879 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir‐boosted darunavir
Number of subjects: 0
Study 33048879 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 0
Study 34347950 — intervention group
Group type: EXPERIMENTAL
Intervention: REGEN-COV (1200 mg subcutaneous injection)
Number of subjects: 1505
Study 34347950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1505
Study 33767311 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld fan (HHF) for symptom control
Number of subjects: 30
Study 33767311 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 30
Study 33767311 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld fan (HHF)
Number of subjects: 30
Study 33767311 — intervention group
Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 30
Study 32568065 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate (starting at 500 mg three times daily, increasing to 1 g three times daily if serum bicarbonate < 22 mmol/l at 3 months)
Number of subjects: 300
Study 32568065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 36126314 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect-based exergame program (n=11)
Number of subjects: 22
Study 33009930 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 67
Study 33009930 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study 32997871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Therapy (CAT) plus Treatment as Usual (TAU)
Number of subjects: 39
Study 32997871 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 39
Study 32997871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Therapy (CAT)
Number of subjects: 39
Study 36117580 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric modified MIND diet
Number of subjects: 37
Study 36117580 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric control diet
Number of subjects: 37
Study 33522061 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-mediated micro-intervention with facilitated reaching using Velcro-affixed mittens and toys.
Number of subjects: 73
Study 33522061 — intervention group
Group type: COMPARATOR
Intervention: Alternative treatment condition involving toy-based interactions with caregivers.
Number of subjects: 73
Study 35999254 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-minute walk test (2mWT)
Number of subjects: 50
Study 33729984 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Hearts Together (HHT) intervention, an 8-week couples-based program
Number of subjects: 0
Study 33729984 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35523485 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicardial injection of hiPSC‐CMs (1×10^8, 2×10^8, and 4×10^8 cells) during CABG surgery
Number of subjects: 0
Study 35523485 — intervention group
Group type: COMPARATOR
Intervention: CABG surgery alone
Number of subjects: 0
Study 34247202 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele score for BMI
Number of subjects: 5424
Study 34247202 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele score for worry
Number of subjects: 5424
Study 34247202 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 5424
Study 33426734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) scan interpretation by physicians
Number of subjects: 20
Study 32471373 — intervention group
Group type: EXPERIMENTAL
Intervention: PMES plus antidepressant
Number of subjects: 258
Study 32471373 — intervention group
Group type: COMPARATOR
Intervention: Sham plus antidepressant
Number of subjects: 258
Study 35382961 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone combined with ropivacaine (5 μg/kg hydromorphone + 0.2% ropivacaine)
Number of subjects: 120
Study 35382961 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 120
Study 33781228 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime Time Sister Circles (PTSC) program, a 13-week multifaceted peer support intervention
Number of subjects: 0
Study 33781228 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime Time Sister Circles (PTSC) program
Number of subjects: 0
Study 32312147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival
Number of subjects: 0
Study 35353129 — intervention group
Group type: EXPERIMENTAL
Intervention: PIMSRA
Number of subjects: 200
Study 32052316 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary cement embolism
Number of subjects: 121
Study 32052316 — intervention group
Group type: COMPARATOR
Intervention: No pulmonary cement embolism (Control)
Number of subjects: 121
Study 35130507 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump training
Number of subjects: 16
Study 35130507 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex training
Number of subjects: 16
Study 35130507 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 16
Study 33729148 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-made protective clothing
Number of subjects: 86
Study 33729148 — intervention group
Group type: COMPARATOR
Intervention: Standard protective clothing
Number of subjects: 86
Study 35568897 — intervention group
Group type: COMPARATOR
Intervention: Full-body resistance training (FB)
Number of subjects: 50
Study 35568897 — intervention group
Group type: COMPARATOR
Intervention: Split-body resistance training (SPLIT)
Number of subjects: 50
Study 35664492 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine 150 mg daily
Number of subjects: 45
Study 35664492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 34457215 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality management by objectives in patient care for persistent vacuum sealing drainage (VSD)
Number of subjects: 164
Study 34457215 — intervention group
Group type: COMPARATOR
Intervention: Original nursing model
Number of subjects: 164
Study 32339235 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy (RT) with concurrent and adjuvant temozolomide (TMZ)
Number of subjects: 1321
Study 32339235 — intervention group
Group type: EXPERIMENTAL
Intervention: Single modality treatment with temozolomide (TMZ)
Number of subjects: 1321
Study 32339235 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter courses of RT
Number of subjects: 1321
Study 35035214 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle fenestration
Number of subjects: 18
Study 35035214 — intervention group
Group type: COMPARATOR
Intervention: Classic muscle recession
Number of subjects: 18
Study 36044559 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment intervention consisting of 7 sessions
Number of subjects: 60
Study 36044559 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 35920662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (2 g) and Taniborbactam (0.5 g) administered as a single intravenous infusion over 2 hours.
Number of subjects: 0
Study 35920662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime and Taniborbactam in subjects with mild, moderate, and severe renal impairment compared to normal renal function.
Number of subjects: 0
Study 35920662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime and Taniborbactam during hemodialysis.
Number of subjects: 0
Study 32507103 — intervention group
Group type: EXPERIMENTAL
Intervention: GA-ANN method
Number of subjects: 43
Study 32507103 — intervention group
Group type: EXPERIMENTAL
Intervention: GA-MLR method
Number of subjects: 43
Study 36409962 — intervention group
Group type: EXPERIMENTAL
Intervention: Four Hmong word recognition lists
Number of subjects: 70
Study 36409962 — intervention group
Group type: COMPARATOR
Intervention: English word list - List 1A of the Northwestern University Auditory Test No. 6
Number of subjects: 70
Study 33276294 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sedation
Number of subjects: 205
Study 33276294 — intervention group
Group type: COMPARATOR
Intervention: Sedation
Number of subjects: 205
Study 32423930 — intervention group
Group type: EXPERIMENTAL
Intervention: XZK 1200 mg once per day (OD group)
Number of subjects: 316
Study 32423930 — intervention group
Group type: COMPARATOR
Intervention: XZK 600 mg two times per day (TD group)
Number of subjects: 316
Study 34215704 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 200-400 mg/day
Number of subjects: 153
Study 34215704 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 153
Study 34215704 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 153
Study 34215704 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) and Placebo
Number of subjects: 153
Study 34702123 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin plus standard treatment
Number of subjects: 0
Study 34702123 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 0
Study 34279564 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily coffee intake
Number of subjects: 386258
Study 34279564 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization study using genetic variants
Number of subjects: 386258
Study 32070302 — intervention group
Group type: EXPERIMENTAL
Intervention: mTAP (a mixture of metronidazole, ciprofloxacin, and cefaclor)
Number of subjects: 45
Study 32070302 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2
Number of subjects: 45
Study 32070302 — intervention group
Group type: COMPARATOR
Intervention: No intracanal medicament (Control)
Number of subjects: 45
Study 32070302 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 45
Study 32070302 — intervention group
Group type: EXPERIMENTAL
Intervention: BC fast set putty
Number of subjects: 45
Study 34010226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (10 sessions of 20 minutes over 2 weeks)
Number of subjects: 20
Study 34010226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation
Number of subjects: 20
Study 35373083 — intervention group
Group type: EXPERIMENTAL
Intervention: FX CorAL 600
Number of subjects: 70
Study 35373083 — intervention group
Group type: COMPARATOR
Intervention: SureFlux 17UX
Number of subjects: 70
Study 35373083 — intervention group
Group type: COMPARATOR
Intervention: Polyflux 170H
Number of subjects: 70
Study 33074913 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive web-based breastfeeding monitoring system
Number of subjects: 106
Study 33074913 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 106
Study 35195808 — intervention group
Group type: EXPERIMENTAL
Intervention: SAD vignette (experimental condition)
Number of subjects: 103
Study 35195808 — intervention group
Group type: COMPARATOR
Intervention: Non-SAD vignette (control condition)
Number of subjects: 103
Study 34343032 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine-Irinotecan-Temozolomide (VIT)
Number of subjects: 120
Study 34343032 — intervention group
Group type: COMPARATOR
Intervention: Vincristine-Irinotecan (VI)
Number of subjects: 120
Study 35548882 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training
Number of subjects: 350
Study 35548882 — intervention group
Group type: EXPERIMENTAL
Intervention: Student workshops
Number of subjects: 350
Study 35548882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both staff and student training
Number of subjects: 350
Study 35548882 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 350
Study 33220354 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra plus methylprednisolone
Number of subjects: 120
Study 33220354 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated historical controls)
Number of subjects: 120
Study 33035457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazemetostat 800 mg orally twice per day in continuous 28-day cycles
Number of subjects: 99
Study 32853747 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term albumin administration
Number of subjects: 0
Study 32853747 — intervention group
Group type: EXPERIMENTAL
Intervention: On-treatment serum albumin levels
Number of subjects: 0
Study 32853747 — intervention group
Group type: COMPARATOR
Intervention: Patients whose on-treatment serum albumin remained below normal
Number of subjects: 0
Study 33462580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (400 µg/kg for 3 days)
Number of subjects: 203
Study 33462580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 33462580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 203
Study 32186237 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupulolith repositioning maneuver (CuRM)
Number of subjects: 49
Study 32186237 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic head‐shaking maneuver
Number of subjects: 49
Study 32186237 — intervention group
Group type: COMPARATOR
Intervention: Modified Lempert maneuver
Number of subjects: 49
Study 36037586 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP/NX flexible model of care with flexible take-home dosing (n = 138)
Number of subjects: 272
Study 36037586 — intervention group
Group type: COMPARATOR
Intervention: Standard model of care with closely supervised methadone (n = 134)
Number of subjects: 272
Study 36037586 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP/NX flexible model of care
Number of subjects: 272
Study 36037586 — intervention group
Group type: COMPARATOR
Intervention: Standard model of care with closely supervised methadone
Number of subjects: 272
Study 33960254 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG-gated photographs
Number of subjects: 30
Study 32014382 — intervention group
Group type: EXPERIMENTAL
Intervention: StepEase™ diabetic socks
Number of subjects: 31
Study 36471403 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) intervention
Number of subjects: 120
Study 36471403 — intervention group
Group type: COMPARATOR
Intervention: Active Control
Number of subjects: 120
Study 32381573 — intervention group
Group type: EXPERIMENTAL
Intervention: Low B cell count
Number of subjects: 340
Study 32381573 — intervention group
Group type: EXPERIMENTAL
Intervention: T cell, macrophage, and Hodgkin-Reed-Sternberg-cell content
Number of subjects: 340
Study 32381573 — intervention group
Group type: EXPERIMENTAL
Intervention: Low B cell content
Number of subjects: 340
Study 32897298 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 36357016 — intervention group
Group type: EXPERIMENTAL
Intervention: Amulet device (dual occlusive mechanism)
Number of subjects: 1593
Study 36357016 — intervention group
Group type: COMPARATOR
Intervention: Watchman 2.5 device (single occlusive mechanism)
Number of subjects: 1593
Study 36357016 — intervention group
Group type: EXPERIMENTAL
Intervention: Peridevice leak (PDL) ≥3 mm
Number of subjects: 1593
Study 32993731 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-HGS
Number of subjects: 148
Study 32993731 — intervention group
Group type: COMPARATOR
Intervention: EUS-AG
Number of subjects: 148
Study 36330670 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 34001462 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiation therapy (SCRT) followed by chemotherapy (FOLFOX ×8 or CAPOX ×5 cycles)
Number of subjects: 19
Study 34001462 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiation therapy (SCRT) followed by chemotherapy
Number of subjects: 19
Study 32736184 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant trials
Number of subjects: 179
Study 34037955 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 30 min per session, 5 times a week for 6 weeks with conventional treatment
Number of subjects: 112
Study 34037955 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 112
Study 34037955 — intervention group
Group type: COMPARATOR
Intervention: Comparison of aerobic exercise plus conventional treatment vs. conventional treatment alone
Number of subjects: 112
Study 32617694 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day SDD group
Number of subjects: 447
Study 32617694 — intervention group
Group type: COMPARATOR
Intervention: 3-day SDD group
Number of subjects: 447
Study 35401732 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (in addition to escitalopram oxalate)
Number of subjects: 118
Study 33782715 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-and-moisture-exchanging mask (HME) during time-trial (TT)
Number of subjects: 23
Study 33782715 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-and-moisture-exchanging mask (HME) during submaximal warm-up (SUB)
Number of subjects: 23
Study 33782715 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-and-moisture-exchanging mask (HME) during SUB
Number of subjects: 23
Study 33782715 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-and-moisture-exchanging mask (HME)
Number of subjects: 23
Study 34077745 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical betamethasone eye drops
Number of subjects: 62
Study 34077745 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative betamethasone)
Number of subjects: 62